ShangPharma Innovation Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 31
  • Portfolio
  • 18
  • Exits
  • 8
Exits

ShangPharma Innovation General Information

Description

Founded in 2016, ShangPharma Innovation is a venture capital and accelerator firm based in San Francisco, California. The firm seeks to invest in and incubate companies operating in the healthcare sector focusing on therapuetic breakthrough, biotechnology and pharmaceuticals.

Contact Information

Website
www.spiivc.com
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • 280 Utah Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

ShangPharma Innovation Investments (31)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Circle Pharma 16-Jun-2021 Later Stage VC 0000 Drug Discovery Generating Revenue
000000 00000000000 17-Mar-2021 0000 00000 0000 Drug Discovery Pre-Clinical Trials
0000000000 06-Nov-2020 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3
0000000000 000 06-Oct-2020 00000 00000 0000 Drug Discovery Generating Revenue
000000 000000 17-Mar-2020 00000 00000 0000 Drug Discovery Generating Revenue 000000 0000 00.0
0000000000 0000000 24-Apr-2019 000000000000 Other Pharmaceuticals and Biotechnology Startup
00000000 00000000 21-Feb-2019 00000 00000 00.00 Drug Discovery Generating Revenue
0000000 0000000000 01-Jan-2019 00000 00000 00000 Biotechnology Generating Revenue
Trisaq 01-Jan-2019 Later Stage VC 000.00 Drug Discovery Out of Business
CAMP4 25-Sep-2018 Early Stage VC 000.00 Other Pharmaceuticals and Biotechnology Generating Revenue
You’re viewing 10 of 31 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ShangPharma Innovation Exits (8)

Company Name Exit Date Exit Type Exit Size
Haystack Sciences 22-Oct-2020 Merger/Acquisition
000000 14-Sep-2020 000 00 00000000
0000000 000000000 05-Jun-2020 000 00000
00000 000000000000 25-Nov-2019 000000000000000000 00000
0000000 0000000000 27-Jun-2019 000 0000
00000 000000000000 01-Jun-2019 000000000000000000 00000
IDEAYA Biosciences 23-May-2019 IPO 0000
Quartet Medicine 20-Nov-2017 Out of Business
To view ShangPharma Innovation’s complete exits history, request access »

ShangPharma Innovation Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

ShangPharma Innovation Team (21)

Name Title Deals Funds Boards Office
Walter Moos Ph.D Chief Executive Officer & Chairman 0 0 South San Francisco, CA
Mohamad Tabrizi Senior Advisor, Senior Vice President and Chief Financial Officer South San Francisco, CA
Ira Smith Ph.D Director South San Francisco, CA
Benson Tsang Additional Executive-in-Residence & Strategic Advisors/Consultants 0 South San Francisco, CA
Eric Parker Ph.D Additional Executive-in-Residence & Strategic Advisors/Consultants South San Francisco, CA
You’re viewing 5 of 21 team members. Get the full list »

ShangPharma Innovation Co-Investors (80)

Name With Exits Lead Partner Series Industry
Alexandria Venture Investments 3 Series chart Industry bar
ShangBay Capital 0 Series chart Industry bar
Atlas Venture 0 0 0 Series chart Industry bar
GV 0 0 0 Series chart Industry bar
Mission Bay Capital 0 0 Series chart Industry bar
You’re viewing 5 of 80 co-investors. Get the full list »